Supplementary Figure S1 from First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti–PD-L1 Antibody ZKAB001

<p>Kaplan-Meier curves for Event-free Survival (EFS) in each dose group</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Yan Zhou (15053225) (author)
Diğer Yazarlar:	Qingcheng Yang (15053228) (author), Yang Dong (15053231) (author), Tong Ji (15053234) (author), Bing Zhang (15053237) (author), Cheng Yang (15053240) (author), Shuier Zheng (15053243) (author), Lina Tang (15053246) (author), Chenliang Zhou (15053249) (author), Guowei Qian (15053252) (author), Yujing Huang (15053255) (author), Wenxi Yu (15053258) (author), Hongtao Li (15053261) (author), Yonggang Wang (15053264) (author), Aina He (15053267) (author), Zan Shen (15053270) (author), Qiyuan Bao (15053273) (author), Yingqi Hua (15053276) (author), Hongyu Bai (15053279) (author), Jiayi Zhao (15053282) (author), Xiaoyi Li (15053285) (author), Xiangrong Dai (15047025) (author), Jianjun Zhang (15053288) (author), Haiyan Hu (15053291) (author), Yang Yao (15053294) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Therapeutic Research and Development Clinical Research and Trials Chemotherapy Clinical-Stage Research Sarcomas Osteosarcoma
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller